A Double-Blinded, Prospective Study to Define Antigenemia and Quantitative Real-Time Polymerase Chain Reaction Cutoffs to Start Preemptive Therapy in Low-Risk, Seropositive, Renal Transplanted Recipients-Reference-Cited by-同舟云学术

A Double-Blinded, Prospective Study to Define Antigenemia and Quantitative Real-Time Polymerase Chain Reaction Cutoffs to Start Preemptive Therapy in Low-Risk, Seropositive, Renal Transplanted Recipients

Published:2014-11-27 Issue:10 Volume:98 Page:1077-1081
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

David-Neto Elias,Triboni Ana H.K.,Paula Flavio J.,Vilas Boas Lucy S.,Machado Clarisse M.,Agena Fabiana,Latif Acram Z.A.,Alencar Cecília S.,Pierrotti Ligia C.,Nahas William C.,Caiaffa-Filho Helio H.,Pannuti Claudio S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference21 articles.

1. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.;Kotton;Transplantation,2010

2. Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy.;Atabani;Am J Transplant,2012

3. Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation.;Emery;J Clin Virol,2012

4. Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection.;Martin-Gandul;J Clin Virol,2013

5. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study.;Sagedal;Nephrol Dial Transplant,2003

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients;Transplantation;2023-11-22

2. Significant Increase in Cytomegalovirus (CMV) Infection in Solid Organ Transplants Associated With Increased Use of Thymoglobulin as Induction Therapy?;Transplantation Proceedings;2023-11

3. Clinical validation of an in-house quantitative real time PCR assay for cytomegalovirus infection using the 1st WHO International Standard in kidney transplant patients;Brazilian Journal of Nephrology;2021-12

4. Local evidence on the cytomegalovirus viral load threshold for preemptive treatment is welcome, and a comment on indirect effects;Brazilian Journal of Nephrology;2021-12

5. Cytomegalovirus Viral Load in Transplanted Patients Using the NeuMoDx™ (Qiagen) Automated System: A 1-Month Experience Feedback;Viruses;2021-08-16